BioNexus Gene Lab Corp. effects 1-for-10 reverse stock split effective April 7, 2025

BioNexus Gene Lab Corp

1-for-10 reverse split effective 12:01 a.m. ET April 7, 2025; shares reduced from 17,967,663 to 1,796,597.
No fractional shares issued; cash payment based on 10-day VWAP prior to effective date (corrects prior cash payment price).
Reverse split aims to regain compliance with Nasdaq Minimum Bid Price Rule by May 1, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.